52 results
8-K
EX-99.1
AXDX
Accelerate Diagnostics Inc
29 Mar 24
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
5:19pm
5%, overall annual revenue was down year-over-year due to a challenging capital sales environment in all our sales regions.
Gross margin
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
change the operating environment for hospitals and managed care organizations. Health care industry participants may react to such legislation … environment for clinical laboratory tests. The measures implemented by PAMA and ACA regulations can result in reduced prices, added costs, and decreased test
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
provisions that may change the operating environment for hospitals and managed care organizations. Health care industry participants may react … ”), changing the payment environment for clinical laboratory tests. The measures implemented by PAMA and ACA regulations can result in reduced prices, added
S-1/A
EX-1.1
gupnvrad iw8iv0
16 Jan 24
IPO registration (amended)
7:18am
8-K
EX-99.1
ggegsy53xqcjk6
8 Jan 24
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
6:03am
S-1
7a9ebk09obp
13 Dec 23
IPO registration
5:30pm
8-K
EX-99.1
1gyuczah 69ic0sn
13 Dec 23
December 2023 Company Presentation
5:05pm
8-K
EX-4.1
6bx5bsdnvliilx5a
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
w9u9h68l7e5vfldr3h
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.2
189ruyhcv0bo x6ydt
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-99.2
8jz ludz9fb
15 Nov 22
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
4:49pm
8-K
EX-1.1
vosv96btxw6of
23 Aug 22
Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
4:11pm